High-dose, short-duration versus standard rifampicin for tuberculosis preventive treatment: a partially blinded, three-arm, non-inferiority, randomised, controlled trial.
Ruslami R, Fregonese F, Apriani L, Barss L, Bedingfield N, Chiang V, Cook VJ, Fisher D, Flores E, Fox GJ, Johnston J, Lim RK, Long R, Paulsen C, Nguyen TA, Nhung NV, Gibson D, Valiquette C, Benedetti A, Menzies D.
Ruslami R, et al. Among authors: benedetti a.
Lancet Respir Med. 2024 Mar 26:S2213-2600(24)00076-6. doi: 10.1016/S2213-2600(24)00076-6. Online ahead of print.
Lancet Respir Med. 2024.
PMID: 38552659